SCIENTIFIC PROGRAM (as of March 13 th, 2018)
|
|
|
- Marshall Gilmore
- 5 years ago
- Views:
Transcription
1 SCIENTIFIC PROGRAM (as of March 13 th, 2018) DAY 1 THURSDAY, 07 JUNE 2018 TOPIC: Sarcoidosis "Granuloma Biology Symposium: Etiology and Pathogenesis of Sarcoidosis/ Part A Chairs: D. Culver, P. Rottoli - Overview of sarcoidosis models, J-F. Bernaudin - Regulation of innate immune responses in sarcoidosis, T. Weichhart - The strange relationship between primary immunodeficiency and sarcoid granulomas: all that glitters is not sarcoidosis, C. Agostini COFFEE BREAK "Granuloma Biology Symposium: Etiology and Pathogenesis of Sarcoidosis/ Part B Chairs: D. Israël Biet, J. Grutters - Genetic determinants of granuloma formation in sarcoidosis, J. Müller- Quernheim - New therapeutic strategies tackling granuloma formation in sarcoidosis, A. Prasse - Non Sarcoid Granulomas, H. Nunes Discussion Discussants: D. Culver, M. Kolb, B. Crestani "Lecture: Iatrogenic respiratory disease: knowns and unknowns Chair: A. Wells Speaker: P. Camus LUNCH BREAK
2 DAY 1 THURSDAY, 07 JUNE 2018 TOPIC: Sarcoidosis (cont.) "Clinical Symposium: Danger versus quality of life Chairs: A. Wells, U. Costabel, N. Tzanakis - Opening conceptual talk, illustrated by identifying danger in pulmonary sarcoidosis, D. Culver - Cardiac sarcoidosis, V. Kouranos - Other forms of dangerous sarcoidosis, U. Costabel - The treatment approach for impaired quality of life, M. Drent Poster Discussion (selected) Chairs: J. Grutters, H. Nunes COFFEE BREAK "Challenges in Pulmonary Hypertension in Sarcoidosis Chairs: D. Valeyre, M. Humbert - The diagnosis of PH in sarcoidosis, O. Sitbon - Pathomechanisms of PH in sarcoidosis, M. Humbert - Treatment data in sarcoidosis, B. Baughman - Trial design and end-points in sarcoidosis, D. Valeyre OPENING CEREMONY Keynote Lecture: Should I treat Pulmonary Hypertension in Chronic Lung Diseases? Speaker: M. Humbert Welcome Messages: - Prof. A. Arata, WASOG President - Prof. M. Gaga, ERS President - Prof. O. Zoras, Rector, University of Crete
3 DAY 2 FRIDAY, 08 JUNE 2018 TOPIC: Pulmonary Fibrosis "Diagnosis in IPF 2018 Chairs: A. Wells, U. Costabel, D. Bouros - The integrated diagnostic pathway in IPF, G. Raghu - BAL: does it still have a major role in ILD diagnosis?, C. Ravaglia - The current role of cryobiopsy in ILD diagnosis, V. Poletti - Surgical biopsy in ILD in 2018, M. Kreuter COFFEE BREAK Debate: Autoimmunity/ inflammation is important in IPF Chairs: B. Crestani, K. Antoniou Pro: C. Vancheri Con: A. Gunther Discussion Emerging Concepts in ILDs Chairs: C. Cordeiro, V. Poletti - ILA: do they hold the key to understanding IPF?, S. Tomasseti - New biomarker data in IPF: do they provide pathogenetic insights?, G. Jenkins - MSCs therapy in IPF, M. Glassberg
4 DAY 2 FRIDAY, 08 JUNE 2018 TOPIC: Pulmonary Fibrosis (cont.) SATELLITE SYMPOSIUM Recent Advances in Fibrosing Interstitial Lung Diseases Sponsored by Boehringer Ingelheim LUNCH BREAK "Selected Oral Presentations Chairs: P. Rottoli, W. Wuyts "Debate: Genetic testing should be performed routinely in IPF Chairs: T. Vassilakopoulos, M.Molina-Molina Pro: B. Crestani Con: J. Grutters Discussion COFFEE BREAK SATELLITE SYMPOSIUM IPF and beyond latest insights Sponsored by Roche International "Diagnosis in ILDs Chairs: A. Wells, K. Antoniou, S. Schiza - Genomic diagnosis in ILDs, M. Molina - Molina - Current imaging in ILD, S. Walsh - Future imaging in ILD, J. Jacob - Multidisciplinary Diagnosis in ILDs, D. Castillo
5 DAY 3 SATURDAY, 09 JUNE 2018 TOPIC: Connective Tissue Disorders & Rare Diseases "CTD and Rare Diseases symposium Chairs: S. Papiris, P. Sidiropoulos (invited) - Genetic insights in the pathogenesis of rheumatoid arthritis - interstitial lung disease, P. Dieudé - IPAF, V. Cottin - Pulmonary alveolar proteinosis, F. Bonella - Pulmonary Hystiocytosis, S. Harari Lecture: Severe Asthma: an orphan disease? Chairs: M. Gaga, M. Humbert Speaker: S. Loukides COFFEE BREAK "Lecture: Update from the 6th World Symposium on Pulmonary Hypertension, Nice 2018 Chair: N. Galie Speaker: M. Humbert "Palliative care in ILD Chairs: C. Cordeiro, Z. Daniil - Overview, M. Wijsenbeek - Insights from clinical practice, E. Lower - Future research in palliative care, S. Bajwah State of the Art Lecture: ANCA-associated vasculitis and the lung - Novel insights Chairs: M. Humbert, K. Antoniou Speaker: L. Mouthon
6 DAY 3 SATURDAY, 09 JUNE 2018 TOPIC: Connective Tissue Disorders & Rare Diseases (cont.) Lecture: Fibrosis, COPD and autoimmunity- common links Chairs: K. Tzanakis, Th. Vassilakopoulos Speaker: K. Antoniou LUNCH BREAK "Clinical trials in ILD Chairs: M. Kolb, P. Rottoli - Future end points, P. Spagnolo - Patient stratification by genomic and biomarker profiles, M. Kolb - Trial design and end-points in ILDs, W. Wuyts "Hot Topics in ILDs Chairs: R. Chambers, B. Crestani - Macrophage lineage and phenotypes in fibrotic disease, A. Byrne - Microbiome in IPF, P. Molyneaux - Cell Senescence in IPF, M. Rojas CLOSING CEREMONY Closing Lecture: Mechanistic overlap between IPF and cancer: focus on the TGFb signaling axis Speaker: R. Chambers
SCIENTIFIC PROGRAM (as of May 9 th, 2018)
SCIENTIFIC PROGRAM (as of May 9 th, 2018) DAY 1 THURSDAY, 07 JUNE 2018 TOPIC: Sarcoidosis 09.30-10.30 "Granuloma Biology Symposium: Etiology and Pathogenesis of Sarcoidosis/ Part A Chairs: D. Culver, P.
SCIENTIFIC PROGRAM (as of February 6 th, 2018)
SCIENTIFIC PROGRAM (as of February 6 th, 2018) DAY 1 THURSDAY, 07 JUNE 2018 TOPIC: Sarcoidosis 09.30-10.30 "Granuloma Biology Symposium: Etiology and Pathogenesis of Sarcoidosis/ Part A Chairs: D. Culver,
Version 1.11 of 20/07/2018
Version 1.11 of 20/07/2018 NICE JANUARY 17-19, 2019 6 th International Workshop on Lung Health New approaches to respiratory diseases PRESIDENTS: F. BLASI, G.W. CANONICA CHAIRMEN: S. CENTANNI, J.C. VIRCHOW,
ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.
ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. to change at any time www.arlar.org info@arlar.org #ArLAR2018 Thursday, 22
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
Diagnosing ILD. What is important in 2016? Chris Grainge
Diagnosing ILD What is important in 2016? Chris Grainge Senior Staff Specialist Respiratory Medicine John Hunter Hospital Conjoint A/Prof University of Newcastle Conflict of interest I have acted as a
NINTEDANIB MEDIA BACKGROUNDER
NINTEDANIB MEDIA BACKGROUNDER 1. What is nintedanib? 2. How does nintedanib work? 3. Data overview 4. International treatment guidelines for IPF 1. What is nintedanib? Nintedanib (OFEV a ) is a small molecule
Differential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
XXII. East Bohemian Respiratory Congress Friday Beginning and welcome talk XXII. East Bohemian Respiratory Congress AULA
XXII. East Bohemian Respiratory Congress Friday 20.4.2018 08.30-09.00 Beginning and welcome talk XXII. East Bohemian Respiratory Congress AULA Salajka F. 09.00-10.00 Future of vaccination in respiratory
INTERNATIONAL MEETING ON PULMONARY RARE DISEASES AND ORPHAN DRUGS PROGRAM ENDORSED BY
INTERNATIONAL MEETING ON PULMONARY RARE DISEASES AND ORPHAN ENDORSED BY PROGRAM DRUGS MILANO ITALY CONGRESS CENTER PALAZZO DELLE STELLINE FEBRUARY 24-25, 2017 PRESIDENT OF THE CONGRESS SERGIO HARARI Division
INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity
PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity
PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
COI: no conflicts of interest to declare
Idiopathic versus secondary Usual Interstitial Pneumonia (UIP) pattern in a series of 96 consecutive surgical lung biopsies: The value of histologic ancillary findings in a multidisciplinary discussion
BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM
PLENARY SESSIONS BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 COFFEE BREAK 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
CTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
ERS monograph. Idiopathic Pulmonary Fibrosis. Edited by Ulrich Costabel, Bruno Crestani and Athol U. Wells
ERS monograph Idiopathic Pulmonary Fibrosis Edited by Ulrich Costabel, Bruno Crestani and Athol U. Wells Idiopathic Pulmonary Fibrosis Edited by Ulrich Costabel, Bruno Crestani and Athol U. Wells Editor
Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME
With an unrestricted grant by Organized by Vall d Hebron Barcelona Hospital Campus Barcelona, Spain International FINAL PROGRAMME Respiratory diseases are among the most frequent causes of mortality and
Autoimmunity in IPF Pathogenesis : Novel insights
Autoimmunity in IPF Pathogenesis : Novel insights Katerina M. Antoniou Lecturer in Thoracic Medicine ERS ILD Group Secretary Medical School, University of Crete IPF DEFINITION IPF is defined as a specific
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
2018 PITTSBURGH INTERNATIONAL LUNG CONFERENCE Pulmonary Medicine: Basic Biology and Novel Therapies
2018 PITTSBURGH INTERNATIONAL LUNG CONFERENCE Pulmonary Medicine: Basic Biology and Novel Therapies PROGRAM AGENDA Thursday, October 4, 2018 7:00 8:00 am Registration, Refreshments, and Poster Viewing
Do randomized clinical trials always provide certain results? The case of tralokinumab in idiopathic pulmonary fibrosis
Page 1 of 6 AJRCCM Articles in Press. Published on 25-August-2017 as 10.1164/rccm.201708-1666ED Do randomized clinical trials always provide certain results? The case of tralokinumab in idiopathic pulmonary
Contents. Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv. Speakers Abstracts
vii Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv Speaker Presentations Speakers Abstracts Wednesday, 6 June 2012 SP0001 Pre-conference outlook... 2 SP0002 WIN Session 1... 2 SP0003 SP0005
Contents. Welcome Address... iii EULAR 2017 Abstracts Reviewers... iv. Speakers Abstracts
vi Welcome Address... iii EULAR 2017 Abstracts Reviewers... iv Speaker Presentations Speakers Abstracts Wednesday, 14 June 2017 SP0001 SP0004 Joint EULAR - APLAR session: novel animal models - where no
FINAL PROGRAMME Version of December 05 th, 2017
FINAL PROGRAMME Version 1.4.2 of December 05 th, 2017 1 Dear Colleagues & Friends, It seems like yesterday that we dared to start this adventure and it gives us great emotion to publish on the cover of
Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar
Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open
PNEUMOLOGIA 2018 Milano, giugno 2018 INTERSTIZIOPATIE E MALATTIE RARE. Il futuro dell IPF: dove stiamo andando. Carlo Albera
PNEUMOLOGIA 2018 Milano, 14 16 giugno 2018 INTERSTIZIOPATIE E MALATTIE RARE Il futuro dell : dove stiamo andando Carlo Albera Università di Torino, Scuola di Medicina Dipartimento di Scienze Cliniche e
TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL)
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 28, 2017
Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party
TIMETABLE Plenary Workshop Special Breaks Optional Event Educational Meet the expert INGID Working Party Wednesday 24 October 2018 I 08:30-09:00 Educational Lecture - Lymphoproliferation in PIDs 09:00-09:30
International Symposium on the Ehlers-Danlos Syndromes
It is with great pleasure that we invite you to participate in the International Symposium on the Ehlers-Danlos Syndromes September 26 29, 2018 The conference will take place in beautiful Ghent, Belgium,
Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy
Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe
September 16, :15 am 3:30 pm Prentice Women s Hospital 250 E. Superior St. Third Floor, Conference Room L South Chicago, Illinois 60611
Third Annual Advances in Pulmonary Medicine CME Symposium September 16, 2016 7:15 am 3:30 pm Prentice Women s Hospital 250 E. Superior St. Third Floor, Conference Room L South Chicago, Illinois 60611 1
Medical School-University of Crete Head: Prof. NIKOLAOS SIAFAKAS MD
LABORATORY OF MOLECULAR AND CELLULAR PULMONOLOGY Medical School-University of Crete Head: Prof. NIKOLAOS SIAFAKAS MD BACKGROUND The Department has published approximately 170 peer-reviewed papers on respiratory
Challenges in the classification of fibrotic ILD
Review SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2015; 32; Suppl. 1: 4-9 Mattioli 1885 Challenges in the classification of fibrotic ILD Elisabeth Bendstrup 1, Toby M. Maher 2, Effrosyni D. Manali
Diagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
SINGAPORE. 12 th PVRI Annual World Congress. on Pulmonary Vascular Disease WELCOME TO. Date // January 2018
Date // 21-25 January 2018 12 th PVRI Annual World Congress on Disease Hotel // Mandarin Orchard Hotel. Singapore WELCOME TO SINGAPORE Pre-Congress MEETINGS Sunday 21 January 2018 PVRI Board of Directors
ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.
ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. www.arlar.org info@arlar.org #ArLAR2018 Pre-Congress Workshop Thursday, 22
ERS School Course Programme Lung Transplantation: Sharing Experience Across Europe February 23-25, 2012 Strasbourg, France
ERS School Course Programme Lung Transplantation: Sharing Experience Across Europe February 23-25, 2012 Strasbourg, France Day 1: Thursday, Date 23. 02. 2012 08:30 08:45 Registration 08:45 09:00 Welcome
Epidemiology and classification of smoking related interstitial lung diseases
Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207
Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease
Disclosures Clinical Approach: Evaluating CTD-ILD for the pulmonologist Industry relationships: Actelion, atyr Pharma, Boehringer-Ingelheim, Genentech- Roche, Gilead Aryeh Fischer, MD Associate Professor
PAOLO SPAGNOLO (SPGPLA69R23L711B)
PAOLO SPAGNOLO (SPGPLA69R23L711B) +39 334 9787789 paolo.spagnolo@unipd.it ELENCO DELLE PUBBLICAZIONI Biondini D, Balestro E, Lacedonia D, Cerri S, Milaneschi R, Luppi F, Cocconcelli E, Bazzan E, Clini
A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel
A case of a patient with IPF treated with nintedanib Prof. Kreuter and Prof. Heussel Case Overview This case describes the history of a patient with IPF who, at the time of diagnosis, had symptoms typical
ERS 2016 Congress Highlights Interstitial Lung Disease (ILD)
ERS 216 Congress Highlights Interstitial Lung Disease (ILD) London, UK September 3 rd 7 th 216 The 26 th European Respiratory Society International Congress, (ERS) the largest respiratory meeting in the
IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK?
IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? KEVIN K. BROWN, MD PROFESSOR AND VICE CHAIRMAN, DEPARTMENT OF MEDICINE NATIONAL JEWISH HEALTH DENVER, CO Kevin K.
E R N - L U N G N e w s l e t t e r. Issue 8. Message from the Coordinator. 1. 2nd ERN-LUNG Board Meeting March 7&8, 2018.
Message from the Coordinator The first year of ERN-LUNG is almost coming to an end and we still have not had our first CROSS BORDER CONSULTATION. We have been building the necessary infrastructure to offer
Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
8th Annual Congress July 2005 "Practical Respiratory Medicine" July 2005 Hilton Kuala Lumpur, Sentral Stesen, Kuala Lumpur
8th Annual Congress July 2005 "Practical Respiratory Medicine" 15-17 July 2005 Hilton Kuala Lumpur, Sentral Stesen, Kuala Lumpur Jointly organised with Malaysian Thoracic Society Important Information
Dr. Daria Manos: Boehringer Ingelheim CSL Behring HIT Global. Dr. Horatiu Muller: No conflicts of interest
Dr. Daria Manos: Boehringer Ingelheim CSL Behring HIT Global Dr. Horatiu Muller: No conflicts of interest Honeycombing Centrilobular emphysema (CLE) Paraseptal emphysema (PSE) Panlobular emphysema Cystic
Advanced Lung Disease Conference
Advanced Lung Disease Conference Novel Therapies and www.dfcon.com Controversies www.bcm.edu/surgical-conference Scientific Program December 7-8 Four Seasons Hotel Houston www.dfcon.com #DFCon17 www.facebook.com/dfcon
SCIENTIFIC PROGRAM. 8:15am Welcome and Introduction Carol Black & Robert Lafyatis
SCIENTIFIC PROGRAM SATURDAY, AUGUST 3 1-5pm Registration / Poster Set-Up SUNDAY, AUGUST 4 8am-6pm Registration 8:15am Welcome and Introduction Carol Black & Robert Lafyatis SESSION 1 Integrative Medicine
Professor Demosthenes Bouros, MD, PhD, FERS, FCCP, FAPSR SHORT CURRICULUM VITAE
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS MEDICAL SCHOOL DEPARTMENT OF PNEUMONOLOGY INTERSTITIAL LUNG DISEASE UNIT HOSPTITAL FOR DISEASES OF THE CHEST SOTIRIA, PANEPISTIMIAKI KLINIKH Professor Demosthenes
SCIENTIFIC PROGRAM. 8:45am Welcome and Introduction Carol Black & Robert Lafyatis
SCIENTIFIC PROGRAM SATURDAY, AUGUST 3 1-5pm Registration / Poster Set-Up SUNDAY, AUGUST 4 8am-6pm Registration 8:45am Welcome and Introduction Carol Black & Robert Lafyatis SESSION 1 Integrative Medicine
INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
Definition, classification and epidemiology
Interstitial Lung Diseases Definition, classification and epidemiology Haluk Türktaş Professor of Pulmonary Medicine Gazi University Ankara Interstitial Lung Diseases Definition of ILD A diverse group
8 th EuroCMR Meeting - Florence 2010 Start: Thursday, End: Saturday (+ CMR exam)
8 th EuroCMR Meeting - Florence 2010 Start: Thursday, 15.00 End: Saturday. 16.30 (+ CMR exam) Thursday; May 27 th, 2010 15.00-19.00 Satellite Symposium on Thalassemia 15.00-18.50 Session I Basic Course
Advanced Lung Disease Conference
Advanced Lung Disease Conference Novel Therapies and www.dfcon.com Controversies www.bcm.edu/surgical-conference Scientific Program December 7-8 Four Seasons Hotel Houston www.dfcon.com #DFCon17 www.facebook.com/dfcon
Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None
Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona
Scientific Program April The 4 th International Congress of the Jordan Rheumatism Society (JRS) CME: 13 Hours
2017 The 4 th International Congress of the Jordan Rheumatism Society (JRS) Organized by: The Jordan Rheumatism Society (JRS) In Collaboration with: The British Society for Rheumatology (BSR) Scientific
Summary: Key Learning Points, Clinical Strategies, and Future Directions
Summary: Key Learning Points, Clinical Strategies, and Future Directions Introduction Idiopathic pulmonary fibrosis (IPF), a peripheral lobular fibrosis of unknown cause, is a chronic, progressive lung
2nd Annual PVRI Symposium & Retreat for Young Investigators
2nd Annual PVRI Symposium & Retreat for Young Investigators 14-17 September 2017 Dorint Pallas Congress Hotel Wiesbaden, Germany The next generation of experts in the field of pulmonary vascular diseases:
Diagnosis of Connective Tissue Disease Interstitial Lung Disease in 2016
Diagnosis of Connective Tissue Disease Interstitial Lung Disease in 2016 A/Prof Tamera Corte TSANZ Annual Conference: Perth 2016 Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University
RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, Sarajevo, Bosnia i Herzegovina
RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, 71000 Sarajevo, Bosnia i Herzegovina http://www.pulmo.co.ba IV CONGRESS OF RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Scientific Agenda Thursday,
PSG 30th Annual Meeting & PSG 32nd Annual Symposium. Friday, April 5 - Monday, April 8, 2019
PSG 30th Annual Meeting & PSG 32nd Annual Symposium Friday, April 5 - Monday, April 8, 2019 Sheraton Grand at Wild Horse Pass Phoenix, Arizona DRAFT: 2.26.19 Parkinson s Foundation Centers Leadership Conference
DIOXIN SYMPOSIUM MEETING PLANNING
DIOXIN SYMPOSIUM MEETING PLANNING History & General Information A listing of future and past Dioxin Symposia can be found on the Symposium page. The International Dioxin Symposium has been held annually
The Fourth International Hemodialysis Course
The Fourth International Hemodialysis Course Urology & Nephrology Center, Mansoura University (October 17th - October 21 st, 2011) It is our pleasure to welcome all of you for your attendance the fourth
Invitation 2-day congress Theatre Flint Amersfoort
Invitation 2-day congress Theatre Flint Amersfoort Dear colleague, It is a great pleasure to invite you to the 29th Annual congress of the European College of Gerodontology to be held from the 15th to
presents October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon K E Y N O T E S E S S I O N
The 57 th annual Montagna Symposium on the Biology of Skin presents The Biologic Basis of Psoriasis October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon Program Chairs Andrew Blauvelt, MD Anne
COPD COPD and Lungs B2B Participation. 9 th International Conference on. March 11-12, 2019 Singapore
COPD 2019 conferenceseries.com 9 th International Conference on COPD and Lungs March 11-12, 2019 Singapore 200+ 12+ 6+ 50+ 3+ 10+ B2B Participation https://copd.conferenceseries.com/ Interactive Sessions
Link and Lead A look in the future and the role of transplant coordinators.
TRANSPLANTATION LEARNING JOURNEY Munich, Germany 6-10 2018 Second announcement 6-7 10 th ELITA 6-7 VCA 7 3 rd ETAHP 7-8 27 th 27 th Congress 3 rd Congress & Workshops Workshops 8 9-10 3 rd 9-10 Link and
Bronchoscopic lung cryobiopsy increases diagnostic confidence. in the multidisciplinary diagnosis of idiopathic pulmonary
Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Sara Tomassetti, Athol U Wells, Ulrich Costabel, Alberto Cavazza, Thomas
January 10-12, Westin Harbour Castle Toronto, ON #CUOS19. cuos2019.org
January 10-12, 2019 Westin Harbour Castle Toronto, ON #CUOS19 cuos2019.org Scientific Program Committee Co-Chairs: Neil Fleshner, CUOG Aly-Khan Lalani, GUMOC Himu Lukka, GUROC Andy Evans, CNUP Tony Finelli,
Preliminary Conference
# better breathing2019 January 25-26 Toronto Marriott Downtown Eaton Centre Preliminary Conference ONTARIO THORACIC SOCIETY About Better Breathing Take advantage of this unique opportunity to participate
23rd Congress of the European Association of Hospital Pharmacists
Tuesday, 20 March 12.00-17.00 Wednesday, 21 March 07.00-17.00 08.30-10.15 Opening ceremony & Keynote 1 - A global view of infectious diseases 10.15 Exhibition opens 10.15-11.45 Coffee break 10.30-11.45
Non-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
Scientific Program Dear Colleagues We are delighted to welcome you at the third Paris NASH Symposium 2017. This French US scientific meeting is a «think tank» aimed to raise future issues in the field
THURSDAY 26 TH APRIL 2018 SCHEDULE PAGE 1 15 TH ANNUAL CRITICAL CARE SYMPOSIUM KING S HOUSE CONFERENCE CENTRE, MANCHESTER
THURSDAY 26 TH APRIL 2018 SCHEDULE PAGE 1 08.00 08.45 Registration 08.45 09.00 Introduction KEYNOTE ADDRESS 09.00 09.30 Non-antibiotic solutions for pan-resistant microbial pathogens Prof Steven Opal SEPSIS
30 th European Heart Diseases and Heart Failure Congress
30 th European Heart Diseases and Heart Failure Congress February 18-19, 2019 - Amsterdam, Netherlands Introduction: I t is a great pleasure and an honour to extend to you a warm invitation to attend the
XXIV World congress on echocardiography and cardiovascular imaging
PROGRAM AT A GLANCE Wednesday, 16 th May /Paradise Blue Hotel, Wind & Sky Hall/ Pre Congress Course Advance in Three Dimensional Echocardiography Teaching Course 8:00-10:00 Registration 10:00-12:00 Session
OFEV MEDIA BACKGROUNDER
OFEV MEDIA BACKGROUNDER 1 What is OFEV (nintedanib*)? 2 How does OFEV (nintedanib*) work? 3 Data overview 4 OFEV (nintedanib*) approval status 1 What is OFEV (nintedanib*)? OFEV (nintedanib*) is a small
CLINICAL VIGNETTE Sarcoidosis: A Case Study Gloria Kim, M.D.
CLINICAL VIGNETTE Sarcoidosis: A Case Study Gloria Kim, M.D. Case Report A 56-year-old female presented to her primary care physician with complaints of dyspnea on exertion and increasing cough. She reported
PRELIMINARY PROGRAMME NHOW MILAN
PRELIMINARY PROGRAMME Via Tortona, 35-20144 Milan (Italy) 1 nd SCIENTIFIC PRELIMINARY PROGRAM Thursday, 18 October 2018 OPENING CEREMONY Chairs: M. Clerici (Italy), S. Esposito (Italy), A. Osterhaus (Germany)
The diagnostic and prognostic utility of
Eur Respir Rev 2010; 19: 117, 237 241 DOI: 10.1183/09059180.00005510 CopyrightßERS 2010 REVIEW: ENDOSCOPY The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease A.U. Wells ABSTRACT:
Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease
Tohoku J. Exp. Med., 2018, 246, 147-153 Pepsin in Bronchoalveolar Lavage Fluid 147 Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease
Pirfenidone: an update on clinical trial data and insights from everyday practice
REVIEW IDIOPATHIC PULMONARY FIBROSIS Pirfenidone: an update on clinical trial data and insights from everyday practice Michael Kreuter 1,2 Affiliations: 1 Dept of Pneumology and Respiratory Critical Care
Experience with the Compassionate Use Program of nintedanib for the treatment of Idiopathic Pulmonary Fibrosis in Argentina
ORIGINAL 131 RAMR 2017;2:131-135 ISSN 1852-236X Correspondence Gabriela Tabaj gabrielatabaj@gmail.com Received: 11.15.2016 Accepted: 02.03.2017 Experience with the Compassionate Use Program of nintedanib
Renowned scientists from each field will highlight ongoing progress in state-of-the-art lectures followed by discussion and case presentations.
Dear colleagues, On behalf of the Porto, Clinical Nephrology Update we are pleased to invite you to attend this event jointly organized by the Nephrology Collaborative Group of the Mayo Clinic and Department
Translating New Immune Pathways into Meaningful Medicines
Translating New Immune Pathways into Meaningful Medicines Cantor Fitzgerald 2018 Global Healthcare Conference Sanjay S. Shukla, M.D., M.S., President & CEO October 2, 2018 Forward-Looking Statements The
State of the Art Symposium
Programme th State of the Art Symposium Programme 20 th State of the Art Symposium Saturday, January 27 th, 2018 Chairpersons Session 1: Session 2: Prof. Britta Engelhardt, Bern PD Dr. Christian Kamm,
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019 HYPERTENSION AND CARDIOVASCULAR DISEASE: Focus on Brain, Cognition, Stroke and Sympathetic Nervous System Activity
Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review
Alsumrain et al. Respiratory Research (2017) 18:161 DOI 10.1186/s12931-017-0644-4 RESEARCH Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large
* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic
APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES Thomas V. Colby, M.D. Mayo Clinic Arizona Geraldine C. Zeiler Professor of Cytopathology Mayo Clinic Arizona Financial Disclosures:
FIRST ANNOUNCEMENT. Organised By. For info:
FIRST ANNOUNCEMENT Organised By Partner with Supported by Media Partner For info: rahja@menageriatricsummit.com Day 1 - December 11 2014 08:00-09:00 Registration, Exhibition, Tea and Coffee 09:00-09:15
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future PRELIMINARY PROGRAM Tuesday, December 4 Wednesday, December 5, 2018 Lerner Hall, Columbia University, New York City, USA Summit Co-Chairs Jerry Shapiro,
INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF)
INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF) Marilyn K. Glassberg Csete, M.D. Professor of Medicine, Surgery, and Pediatrics Director, Interstitial and Rare Lung Disease Program
Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018
Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018 Wellcome Genome Campus, Hinxton, Cambridge, UK Conference Programme Wednesday 5 December 2018 12:00-13:00 Registration
Original Article Clinical value of serum KL-6 for lung diseases in patients with polymyositis and dermatomyositis
Int J Clin Exp Pathol 2017;10(3):3310-3314 www.ijcep.com /ISSN:1936-2625/IJCEP0045527 Original Article Clinical value of serum KL-6 for lung diseases in patients with polymyositis and dermatomyositis Yumeng